• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  methotrexate oral liquid formulation
Date Designated:  03/18/2015
Orphan Designation:  Treatment of acute lymphoblastic leukemia in pediatric patients aged 0 through 16 years.
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Chesapeake Therapeutics
1498-M Reistertown Road
Suite 313
Pikesville, Maryland 21208
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.